Join a team dedicated to understanding the genetics of childhood cancer in St. Jude's Division of Cancer Predisposition
St. Jude Children's Research Hospital
St. Jude Children’s Research Hospital
We seek a highly motivated faculty-level investigator (clinician scientist track) with training in hematology and oncology and a strong interest in genetics to participate in clinical and research initiatives in cancer genomics. The faculty member will be housed in the Division of Cancer Predisposition, a newly formed Section within the Department of Oncology that is dedicated to the evaluation and management of children and families at increased genetic risk for cancer.
The Division provides a highly collaborative and interactive environment where the faculty member will have ample opportunities to participate in clinical, educational and translational research initiatives centered around clinical germline and tumor genomics and the integration of genomic information into patient care. As an integral member of a team of other physician-investigators, genetic counselors and nurses, the faculty member will be able to carry out research projects focused on advancing understanding of childhood cancers and improving upon their treatment. The faculty member will have access to research assistants, computational biologists, genome scientists, and many other resources, which will facilitate their research investigations and ensure their success.
Successful candidates will have expertise in the areas of hematology and oncology and interest in cancer genetics. Candidates should have an MD, MD/PhD or DO degree and be Board certified or Board-eligible in clinical genetics and/or hematology-oncology (pediatric or adult).
About St. Jude Children’s Research Hospital
St. Jude Children's Research Hospital's mission is to advance cures, and means of prevention, for pediatric catastrophic diseases through research and treatment. Consistent with the vision of our founder Danny Thomas, no child is denied treatment based on race, religion or a family's ability to pay.
St. Jude is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20 percent to 80 percent since the hospital opened more than 50 years ago.
St. Jude has been named a top pediatric cancer hospital on U.S. News & World Report’s annual "Best Hospitals" list for 10 years and named to Fortune magazine’s "100 Best Companies to Work For" for nine consecutive years.
Follow us to discover the research, scientific discoveries, clinical care and employment opportunities at St. Jude. View our career opportunities at www.stjude.org/JoinOurMission. Follow St. Jude across social media at @stjuderesearch.
Posted May 1, 2021